MiR-33

Last updated
miR-33a
Mir-33 SS.png
Conserved secondary structure of miR-33a microRNA precursor
Identifiers
SymbolmiR-33a
Alt. Symbolsmir33a
Rfam RF00667
miRBase MI0000091
miRBase family MIPF0000070
NCBI Gene 407039
HGNC 31634
Other data
RNA typemiRNA
Domain(s) Metazoa
GO 0035195
SO 0001244
Locus Chr. 22 q13.2
PDB structures PDBe
miR-33b
Identifiers
SymbolmiR-33b
Alt. Symbolsmir33b
Rfam RF00667
miRBase MI0003646
miRBase family MIPF0000070
NCBI Gene 693120
HGNC 32791
Other data
RNA typemiRNA
Domain(s) Metazoa
GO 0035195
SO 0001244
Locus Chr. 17 13.2
PDB structures PDBe

miR-33 is a family of microRNA precursors, which are processed by the Dicer enzyme to give mature microRNAs. [1] miR-33 is found in several animal species, including humans. In some species there is a single member of this family which gives the mature product mir-33. In humans there are two members of this family called mir-33a and mir-33b, which are located in intronic regions within two protein-coding genes for Sterol regulatory element-binding proteins (SREBP-2 and SREBP-1) respectively. [2]

Contents

Function

miR-33 plays a role in lipid metabolism; it downregulates a number of ABC transporters, including ABCA1 and ABCG1, which in turn regulate cholesterol and HDL generation. [3] [4] Further related roles of miR-33 have been proposed in fatty acid degradation and in macrophage response to low-density lipoprotein. [2] It has been suggested that miR-33a and miR-33b regulates genes Involved in fatty acid metabolism and insulin signalling. [5]

Potential binding sites for mir-33 have been identified in the cDNA of tumour suppressor p53. [6] Further, study has shown that miR-33 is able to repress p53 expression and p53-induced apoptosis. This function is thought to be related to hematopoietic stem cell renewal. [7]

Applications

miR-33, along with miR-122, could be used to diagnose or treat conditions related to metabolic disorders and cardiovascular disease. [2] [8]

Related Research Articles

<span class="mw-page-title-main">Atherosclerosis</span> Form of arteriosclerosis

Atherosclerosis is a pattern of the disease arteriosclerosis, characterized by development of abnormalities called lesions in walls of arteries. These lesions may lead to narrowing of the arterial walls due to buildup of atheromatous plaques. At onset there are usually no symptoms, but if they develop, symptoms generally begin around middle age. In severe cases, it can result in coronary artery disease, stroke, peripheral artery disease, or kidney disorders, depending on which body parts(s) the affected arteries are located in the body.

microRNA Small non-coding ribonucleic acid molecule

MicroRNA (miRNA) are small, single-stranded, non-coding RNA molecules containing 21 to 23 nucleotides. Found in plants, animals and some viruses, miRNAs are involved in RNA silencing and post-transcriptional regulation of gene expression. miRNAs base-pair to complementary sequences in mRNA molecules, then silence said mRNA molecules by one or more of the following processes:

  1. Cleavage of the mRNA strand into two pieces,
  2. Destabilization of the mRNA by shortening its poly(A) tail, or
  3. Reducing translation of the mRNA into proteins.
<span class="mw-page-title-main">HMG-CoA reductase</span> Mammalian protein found in Homo sapiens

HMG-CoA reductase is the rate-controlling enzyme of the mevalonate pathway, the metabolic pathway that produces cholesterol and other isoprenoids. HMGCR catalyzes the conversion of HMG-CoA to mevalonic acid, a necessary step in the biosynthesis of cholesterol. Normally in mammalian cells this enzyme is competitively suppressed so that its effect is controlled. This enzyme is the target of the widely available cholesterol-lowering drugs known collectively as the statins, which help treat dyslipidemia.

In biochemistry, lipogenesis is the conversion of fatty acids and glycerol into fats, or a metabolic process through which acetyl-CoA is converted to triglyceride for storage in fat. Lipogenesis encompasses both fatty acid and triglyceride synthesis, with the latter being the process by which fatty acids are esterified to glycerol before being packaged into very-low-density lipoprotein (VLDL). Fatty acids are produced in the cytoplasm of cells by repeatedly adding two-carbon units to acetyl-CoA. Triacylglycerol synthesis, on the other hand, occurs in the endoplasmic reticulum membrane of cells by bonding three fatty acid molecules to a glycerol molecule. Both processes take place mainly in liver and adipose tissue. Nevertheless, it also occurs to some extent in other tissues such as the gut and kidney. A review on lipogenesis in the brain was published in 2008 by Lopez and Vidal-Puig. After being packaged into VLDL in the liver, the resulting lipoprotein is then secreted directly into the blood for delivery to peripheral tissues.

<span class="mw-page-title-main">Sterol regulatory element-binding protein</span> Protein family

Sterol regulatory element-binding proteins (SREBPs) are transcription factors that bind to the sterol regulatory element DNA sequence TCACNCCAC. Mammalian SREBPs are encoded by the genes SREBF1 and SREBF2. SREBPs belong to the basic-helix-loop-helix leucine zipper class of transcription factors. Unactivated SREBPs are attached to the nuclear envelope and endoplasmic reticulum membranes. In cells with low levels of sterols, SREBPs are cleaved to a water-soluble N-terminal domain that is translocated to the nucleus. These activated SREBPs then bind to specific sterol regulatory element DNA sequences, thus upregulating the synthesis of enzymes involved in sterol biosynthesis. Sterols in turn inhibit the cleavage of SREBPs and therefore synthesis of additional sterols is reduced through a negative feed back loop.

In chemistry, de novo synthesis is the synthesis of complex molecules from simple molecules such as sugars or amino acids, as opposed to recycling after partial degradation. For example, nucleotides are not needed in the diet as they can be constructed from small precursor molecules such as formate and aspartate. Methionine, on the other hand, is needed in the diet because while it can be degraded to and then regenerated from homocysteine, it cannot be synthesized de novo.

<span class="mw-page-title-main">Liver X receptor</span> Nuclear receptor

The liver X receptor (LXR) is a member of the nuclear receptor family of transcription factors and is closely related to nuclear receptors such as the PPARs, FXR and RXR. Liver X receptors (LXRs) are important regulators of cholesterol, fatty acid, and glucose homeostasis. LXRs were earlier classified as orphan nuclear receptors, however, upon discovery of endogenous oxysterols as ligands they were subsequently deorphanized.

mir-133 microRNA precursor family

mir-133 is a type of non-coding RNA called a microRNA that was first experimentally characterised in mice. Homologues have since been discovered in several other species including invertebrates such as the fruitfly Drosophila melanogaster. Each species often encodes multiple microRNAs with identical or similar mature sequence. For example, in the human genome there are three known miR-133 genes: miR-133a-1, miR-133a-2 and miR-133b found on chromosomes 18, 20 and 6 respectively. The mature sequence is excised from the 3' arm of the hairpin. miR-133 is expressed in muscle tissue and appears to repress the expression of non-muscle genes.

The miR-34 microRNA precursor family are non-coding RNA molecules that, in mammals, give rise to three major mature miRNAs. The miR-34 family members were discovered computationally and later verified experimentally. The precursor miRNA stem-loop is processed in the cytoplasm of the cell, with the predominant miR-34 mature sequence excised from the 5' arm of the hairpin.

<span class="mw-page-title-main">Sterol regulatory element-binding protein 1</span> Protein-coding gene in the species Homo sapiens

Sterol regulatory element-binding transcription factor 1 (SREBF1) also known as sterol regulatory element-binding protein 1 (SREBP-1) is a protein that in humans is encoded by the SREBF1 gene.

miR-155 Non-coding RNA in the species Homo sapiens

MiR-155 is a microRNA that in humans is encoded by the MIR155 host gene or MIR155HG. MiR-155 plays a role in various physiological and pathological processes. Exogenous molecular control in vivo of miR-155 expression may inhibit malignant growth, viral infections, and enhance the progression of cardiovascular diseases.

mir-31

miR-31 has been characterised as a tumour suppressor miRNA, with its levels varying in breast cancer cells according to the metastatic state of the tumour. From its typical abundance in healthy tissue is a moderate decrease in non-metastatic breast cancer cell lines, and levels are almost completely absent in mouse and human metastatic breast cancer cell lines. Mir-31-5p has also been observed upregulated in Zinc Deficient rats compared to normal in ESCC and in other types of cancers when using this animal model. There has also been observed a strong encapsulation of tumour cells expressing miR-31, as well as a reduced cell survival rate. miR-31's antimetastatic effects therefore make it a potential therapeutic target for breast cancer. However, these two papers were formally retracted by the authors in 2015.

mir-451 microRNA

In molecular biology mir-451 microRNA is a short RNA molecule. MicroRNAs function to regulate the expression levels of other genes by several mechanisms.

mir-210 microRNA

In molecular biology mir-210 microRNA is a short RNA molecule. MicroRNAs function to regulate the expression levels of other genes by several mechanisms.

miR-27 Family of microRNA precursors found in animals

miR-27 is a family of microRNA precursors found in animals, including humans. MicroRNAs are typically transcribed as ~70 nucleotide precursors and subsequently processed by the Dicer enzyme to give a ~22 nucleotide product. The excised region or, mature product, of the miR-27 precursor is the microRNA mir-27.

In molecular biology mir-365 microRNA is a short RNA molecule. MicroRNAs function to regulate the expression levels of other genes by several mechanisms.

In molecular biology mir-370 microRNA is a short RNA molecule. MicroRNAs function to regulate the expression levels of other genes by several mechanisms. This microRNA, mir-370-3p, has been shown to play a role in heart failure. The upregulation of mir-370-3p in the sinus node leads to downregulation of the pacemaker ion channel, HCN4, and thus downregulation of the corresponding ionic current, which causes sinus bradycardia.

mir-612 microRNA is a short non-coding RNA molecule belonging both to the family of microRNAs and to that of small interfering RNAs (siRNAs). MicroRNAs function to regulate the expression levels of other genes by several mechanisms, whilst siRNAs are involved primarily with the RNA interference (RNAi) pathway. siRNAs have been linked through some members to the regulation of cancer cell growth, specifically in prostate adenocarcinoma.

In molecular biology mir-885 microRNA is a short RNA molecule. MicroRNAs function to regulate the expression levels of other genes by several mechanisms.

<span class="mw-page-title-main">MIR34A</span> Non-coding RNA in the species Homo sapiens

MicroRNA 34a (miR-34a) is a MicroRNA that in humans is encoded by the MIR34A gene.

References

  1. Ambros V (2001). "microRNAs: tiny regulators with great potential". Cell. 107 (7): 823–826. doi: 10.1016/S0092-8674(01)00616-X . PMID   11779458. S2CID   14574186.
  2. 1 2 3 Najafi-Shoushtari SH (Jun 2011). "MicroRNAs in cardiometabolic disease". Current Atherosclerosis Reports. 13 (3): 202–7. doi:10.1007/s11883-011-0179-y. PMID   21461683. S2CID   22595987.
  3. Fernández-Hernando C, Suárez, Y, Rayner, KJ, Moore, KJ (Apr 2011). "MicroRNAs in lipid metabolism". Current Opinion in Lipidology. 22 (2): 86–92. doi:10.1097/MOL.0b013e3283428d9d. PMC   3096067 . PMID   21178770.
  4. Moore KJ, Rayner, KJ, Suárez, Y, Fernández-Hernando, C (Dec 2010). "microRNAs and cholesterol metabolism". Trends in Endocrinology and Metabolism. 21 (12): 699–706. doi:10.1016/j.tem.2010.08.008. PMC   2991595 . PMID   20880716.
  5. Dávalos A, Goedeke L, Smibert P, et al. (May 2011). "miR-33a/b contribute to the regulation of fatty acid metabolism and insulin signaling". Proc. Natl. Acad. Sci. U.S.A. 108 (22): 9232–7. Bibcode:2011PNAS..108.9232D. doi: 10.1073/pnas.1102281108 . PMC   3107310 . PMID   21576456.
  6. Herrera-Merchan A, Cerrato, C, Luengo, G, Dominguez, O, Piris, MA, Serrano, M, Gonzalez, S (Aug 15, 2010). "miR-33-mediated downregulation of p53 controls hematopoietic stem cell self-renewal". Cell Cycle. 9 (16): 3277–85. doi: 10.4161/cc.9.16.12598 . PMID   20703086.
  7. Fuster JJ, Andrés, V (Sep 1, 2010). "A role for miR-33 in p53 regulation: New perspectives for hematopoietic stem cell research". Cell Cycle. 9 (17): 3397–8. doi:10.4161/cc.9.17.13070. PMID   20861665. S2CID   2260421.
  8. Najafi-Shoushtari SH, Kristo, F, Li, Y, Shioda, T, Cohen, DE, Gerszten, RE, Näär, AM (Jun 18, 2010). "MicroRNA-33 and the SREBP host genes cooperate to control cholesterol homeostasis". Science. 328 (5985): 1566–9. Bibcode:2010Sci...328.1566N. doi:10.1126/science.1189123. PMC   3840500 . PMID   20466882.